Source - RNS
RNS Number : 0929I
Intl. Biotechnology Trust PLC
14 June 2017
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC (the Company)

 

 

Portfolio Update as at 31 May 2017

 

Net Assets

£227m

Net Assets per share

603p

Share price

572p

Total value of unquoted investments

£23m

Total number of portfolio companies

91

Dividend

4% of NAV per annum

 

Top Ten Quoted Investments

 

Company Name

% NAV

Celgene

7.6

Regeneron

7.6

Genmab

5.6

Vertex

5.5

Biogen

5.2

Shire

4.0

Alexion

3.6

Incyte

3.4

Aerie

2.9

Biomarin

2.8


-----------

Total

48.2

 

Geographical Allocation

% NAV

US & Canada

80

Europe & UK

20


-----------

Total

100

 

 

Quoted/Unquoted Allocation

% NAV

Quoted

90

Unquoted

10


-----------

Total

100

 

 

NAV % Market Cap

% NAV

Large Cap >USD10BN

53

Mid Cap =USD1-10BN

22

Small Cap <USD1BN

25


-----------

Total

100

 

 

NAV % by Therapeutic Areas

% NAV

Oncology

34

Orphan

13

CNS

11

Ophthalmology

11

Inflammation

7

Medtech

2

Other

22


-----------

Total

100

 

                                        

 

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

14 JUNE 2017


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBDGDLLDBBGRS